FDA proposes randomized, controlled testing for incontinence devices

10/5/2008 | FDAnews

The easiest way to obtain data on the safety and effectiveness of urinary incontinence devices is to conduct randomized, controlled clinical studies, according to an FDA draft guidance. Such trials can help overcome major issues in testing the products, including the diversity of the general patient population. The agency will accept comments on the draft until Dec. 18.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA